Table 4.
The overall treatment for 26 patients with stage IV GTN
| Initial chemotherapy | Salvage treatment | Surgery | Status |
|---|---|---|---|
| TP | Cranial local radiotherapy, Apatinib | Hysterectomy, craniotomy | Dead |
| EP-EMA | Cranial local radiotherapy | Hysterectomy, lesionectomy | NED |
| FAEV | EMA-CO, EP-EMA, TP | Lesionectomy | NED |
| EMA-CO | – | – | NED |
| EMA-CO | – | Craniotomy | NED |
| EMA-CO | – | – | NED |
| EMA-CO | EP-EMA | – | NED |
| EMA-CO (intrathecal) | – | – | Under treatment |
| FA | EP-EMA, FAEV | Hysterectomy | Lost |
| EMA-CO | FCA, EP-EMA | Hysterectomy | Lost |
| MTX | – | Lesionectomy | NED |
| FA | EMA-CO | Hysterectomy, lesionectomy | Dead |
| EMA-CO | Cranial local radiotherapy, FEP, EP-EMA | – | Dead |
| EP-EMA | – | Lesionectomy | NED |
| FA | EMA-CO, EP-EMA, TP | – | Dead |
| EMA-CO | – | Hysterectomy | NED |
| EMA-CO | FAEV, TP, TEP, BEP, MBE, EP-EMA, immunotherapy | Hysterectomy, lesionectomy | Dead |
| EMA-CO | – | Craniotomy | NED |
| EMA-CO | – | Lesionectomy | NED |
| ACM | EP-EMA, TP | Hysterectomy | Dead |
| EMA-CO | EP-EMA | – | NED |
| FA | Cranial local radiotherapy, immunotherapy | Hysterectomy | Dead |
| EMA-CO | – | Craniotomy | NED |
| EP-EMA | – | Hysterectomy | NED |
| EMA-CO | EP-EMA, TP | Hysterectomy | Under treatment |
| EMA-CO | – | – | NED |
FA 5-fluorouracil, actinomycin-D, FCA 5-fluorouracil, cyclophosphamide, actinomycin-D, FEP floxuridine, etoposide, cisplatin, ACM actinomycin-D, cyclophosphamide, methotrexate